UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

4CPS-313 Experience of the use of baricitinib in COVID-19 pneumonia

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A71-A71

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-405 Strongyloides stercoralis prophylaxis with ivermectin in COVID-19 patients

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A115-A116

2021

Link zum Volltext

Verfügbarkeit prüfen

6ER-028 Baricitinib against severe COVID-19: effectiveness and safety in hospital care

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A169-A169

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-214 ‘Unit dose’: clinical risk management of COVID-19 patients treated with hydroxychloroquine

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A160-A160

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-031 Subgroup analysis about efficacy of early use of remdesivir in COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A7-A7

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-221 Safety profile of experimental therapies used in the COVID-19 pandemic based on data from the National Minimum Data Set

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A163-A163

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A14-A15

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-190 Experience and satisfaction of outpatients in the development of a programme for home medication delivery

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A149-A149

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-213 Hospital admissions after discharge from the emergency department to home with COVID-19 treatment

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A159-A160

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-029 Off-label drugs: use analysis and pharmacoepidemiology in a COVID centre in Rome

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A6-A6

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-168 Interest and implementation of rapid daratumumab infusion during the health crisis

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A138-A139

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-260 Analysis of drugs interactions between coronavirus (COVID-19) antiviral treatment and concomitant medication

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A45-A45

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-317 Immunosuppressive treatment management in a cohort of hospitalised solid organ recipients affected by COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A73-A73

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-331 Inflammatory parameter analysis in severe COVID-19 patients treated with tocilizumab

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A80-A80

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-384 Potential drug related problems in the time of COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A105-A106

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-333 Treating multiple sclerosis patients with infusion of disease modifying treatments during the COVID-19 pandemic

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A81-A81

2021

Link zum Volltext

Verfügbarkeit prüfen

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A165-A166

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-210 Effect of monoclonal antibodies to prevent progression to severe COVID-19 disease: real-life data of a university hospital

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A94-A94

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-070 The clinical pharmacist: an essential actor in times of crisis

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A47-A47

2023

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-066 Adequacy to protocol of use of tocilizumab for management of covd-19 disease

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A135-A135

2023

Link zum Volltext

Verfügbarkeit prüfen

3PC-015 In-use stability of Comirnaty and Spikevax clinical solutions: Pfizer-BioNTech and Moderna COVID-19 vaccines: a comparative study from a hospital pharmacy perspective

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A17-A17

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-186 Effectiveness and safety of cilgavimab/tixagevimab in pre-exposure prophylaxis of COVID-19

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A84-A84

2023

Link zum Volltext

Verfügbarkeit prüfen

6ER-020 Prescription and use of liposomal amphotericin b during the COVID-19 pandemic

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A165-A165

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-105 Cefiderocol treatment in COVID-19 positive patients co-infected with pan-resistant pseudomonas aeruginosa

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A57-A57

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-007 Targeting patients with pneumonia by COVID-19 that could be beneficiated by colchicine

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A26-A26

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 154

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBmj Global Health

ThemaPharmacy

KollektionBMJ Journals

Zeitschrift / SerieEuropean Journal Of Hospital Pharmacy. Science And Practice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(150)

Publikationsform

Artikel
(154)

Sprache

Englisch
(154)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Coronaviruses
(154)
Covid-19
(125)
Conflicts Of Interest
(91)
Life Sciences & Biomedicine
(61)
Pharmacology & Pharmacy
(61)
Science & Technology
(61)
Pandemics
(58)
Severe Acute Respiratory Syndrome Coronavirus 2
(53)
Patients
(42)
Drug Stores
(33)
Humans
(31)
Covid-19 Vaccines
(28)
Pharmacists
(28)
Clinical Medicine
(22)
Section 4: Clinical Pharmacy Services
(22)
Hospitals
(21)
Pneumonia
(19)
Critical Care
(18)
Drug Dosages
(18)
Immunization
(18)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB-FREE-00999 freely available EZB journals
(154)
Journals@Ovid Complete
(154)
BMJ
(154)
MEDLINE
(36)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

4CPS-313 Experience of the use of baricitinib in COVID-19 pneumonia

4CPS-405 Strongyloides stercoralis prophylaxis with ivermectin in COVID-19 patients

6ER-028 Baricitinib against severe COVID-19: effectiveness and safety in hospital care

5PSQ-214 ‘Unit dose’: clinical risk management of COVID-19 patients treated with hydroxychloroquine

2SPD-031 Subgroup analysis about efficacy of early use of remdesivir in COVID-19

5PSQ-221 Safety profile of experimental therapies used in the COVID-19 pandemic based on data from the National Minimum Data Set

2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care

5PSQ-190 Experience and satisfaction of outpatients in the development of a programme for home medication delivery

5PSQ-213 Hospital admissions after discharge from the emergency department to home with COVID-19 treatment

2SPD-029 Off-label drugs: use analysis and pharmacoepidemiology in a COVID centre in Rome

5PSQ-168 Interest and implementation of rapid daratumumab infusion during the health crisis

4CPS-260 Analysis of drugs interactions between coronavirus (COVID-19) antiviral treatment and concomitant medication

4CPS-317 Immunosuppressive treatment management in a cohort of hospitalised solid organ recipients affected by COVID-19

4CPS-331 Inflammatory parameter analysis in severe COVID-19 patients treated with tocilizumab

4CPS-384 Potential drug related problems in the time of COVID-19

4CPS-333 Treating multiple sclerosis patients with infusion of disease modifying treatments during the COVID-19 pandemic

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

4CPS-210 Effect of monoclonal antibodies to prevent progression to severe COVID-19 disease: real-life data of a university hospital

4CPS-070 The clinical pharmacist: an essential actor in times of crisis

5PSQ-066 Adequacy to protocol of use of tocilizumab for management of covd-19 disease

3PC-015 In-use stability of Comirnaty and Spikevax clinical solutions: Pfizer-BioNTech and Moderna COVID-19 vaccines: a comparative study from a hospital pharmacy perspective

4CPS-186 Effectiveness and safety of cilgavimab/tixagevimab in pre-exposure prophylaxis of COVID-19

6ER-020 Prescription and use of liposomal amphotericin b during the COVID-19 pandemic

4CPS-105 Cefiderocol treatment in COVID-19 positive patients co-infected with pan-resistant pseudomonas aeruginosa

4CPS-007 Targeting patients with pneumonia by COVID-19 that could be beneficiated by colchicine

Aktive Filter

Suchergebnisse filtern